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Abstract 
 
Background: The kidney is tasked with a number of metabolic functions in the body. In its role as a detoxifier and primary 
eliminator of xenobiotics, it becomes vulnerable to developing injuries. Currently, over 1 million people in the world are living on 
renal replacement therapies (RRTs). The case in sub-Sahara African countries like Nigeria and South Africa is not any better than the 
global trend.  
Materials and Methods: A systematic review of medicinal plants used in the treatment of kidney disorders was conducted. 
Information were gathered from published scientific journals, books, reports from national, regional and international institutions, 
conference proceedings and other high profile intellectual resources. MeSH words like ‘prevalence of kidney disorders in Africa’, 
‘renal replacement therapy’, ‘nephrotoxins or nephrotoxicants’, ‘nephroprotective plants’, ‘nephroprotective plants in Nigeria or 
South Africa’ and ‘nephroprotective phytocompounds’ were used to retrieve information from online databases (Google, Pubmed, 
MEDLINE, Science Direct, Scopus and SID).  
Results: Interestingly, our findings revealed that phytotherapy has emerged and is being employed to protect renal functions and 
delay progression of renal pathological conditions into end episodes where the last resort is RRT. In fact, in recent times, 
Phytotherapists are not only interested in developing relatively safe, more affordable, easily accessible and potent nephroprotective 
formulations but also increasing awareness on the prevalence of the disease and educating the populace on the probable preventive 
measures. More importantly, efforts at scientifically elucidating the pharmacological efficacy of the identified nephroprotective 
plants yet to be validated must be intensified through informed expert opinions. Till date, there is paucity of information on the 
concept of nephroprotection in most developing countries where kidney disorder is a major threat. Although, the concept is just 
emerging in South Africa, evidences have given credence to its application in complementary and alternative system of medicine in 
Nigeria. 
Conclusion: This review, therefore, reawaken researchers’ consciousness in the continuous search for auspicious nephroprotective 
plants that could potentially be excellent candidates in developing new lead drugs to manage and treat renal disorders. 
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Introduction  
 
The kidneys are a pair of fist-sized organs located outside the peritoneal cavity on each side of the spine. They are highly 
specialized organs that maintain the body’s homeostasis by selectively excreting or retaining various substances according to specific 
body needs. The importance of urine formation and excretion as a life-sustaining function is highlighted in situations when kidney 
function is suddenly lost. The complex nature of renal diseases and their progression to renal failure and end stage renal disease 
(ESRD) makes its management quite difficult. Many cases of renal disease (largely due to chemical exposure, reckless lifestyles, and 
complication from metabolic ailments) remain unnoticed until they progress to advance stages when the conventional therapeutic 
interventions are usually not sufficient to provide ample remedy, hence, the name ‘silent killer disease’. The major problem with 
kidney disease however is its progression to a stage when the last resort is the renal replacement therapy (RRT). 
In recognition of the importance of the kidney and its affiliated disorders, the second Thursday of every March has been 
designated as ‘World Kidney Day’.  It is a day set aside by international bodies to re-awaken human consciousness on the 
significance of a healthy kidney and the inherent burden of its disorders to health. This review, thus, examines the common 
nephrotoxins, and the ambit of traditional systems of medicine in providing affordable, relatively safe, and easily accessible renal 
healthcare in Nigeria and South Africa. In 2014, the World Health Organization (WHO) estimated about 300 million people as 
victims of Chronic Kidney Disease (CKD) worldwide with 3.4 million attributable death cases and even more in 2012 and 2013 
respectively (WHO, 2014). In sub-Saharan Africa countries including Nigeria, the numbers are more disconcerting. An estimated 
36.8 million Nigerians (23 percent) were reported to be suffering from various stages of kidney disease. With this figure, one in 
seven Nigerians is at risk of the different forms of the disease (WHO, 2014). In South Africa on the other hand, inherited 
hypertension and Type 2 diabetes account for between 60-65% and 20-25%, respectively of kidney failure in adults (NKFS, 2015). 
With nephropathy as one of the secondary complications of diabetes, the prevalence of renal disorders is even more daunting in 
South Africa which tops the list with an average of 8.3% and closely followed by Nigeria (4.5%) in Africa (IDF, 2014). This singular 
fact has placed these countries in the beam light and as requiring concerted and optimized attention in this region of the world. 
The two frontiers of RRT (dialysis and kidney transplantation) are highly sophisticated and expensive for the average 
income class. Only limited fraction of the elite population can take the luxury of such a regimen subject to the availability of this 
facility. That is why most of the patients of kidney disease are left to die mainly in developing countries because of non-availability 
of RRT facilities or their inability to afford it. A recent report by Saraladevi (2013) suggests that dialysis treatment rate ranges from < 
1 per million populations (pmp) for most sub-Saharan countries, with Nigeria and South Africa at 1.3 and 125 pmp respectively. The 
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growth in dialysis in South Africa is primarily in the private sector, with improved benefits for dialysis for people on medical 
insurance. The average cost of hemodialysis in Africa is $100 per session (Saraladevi, 2013). Renal transplantation on the other hand 
is available in only seven countries in sub-Saharan Africa (South Africa, Sudan, Nigeria, Mauritius, Kenya, Rwanda, and Ghana) 
with most of the transplants being living donor transplants, except in South Africa, where deceased donor transplants are also 
encouraged at ratio 2:3, respectively. Lack of legal framework, religious, and social constraints have hindered deceased donor 
practice in many countries and have led to the low rate of transplantation in these areas. Except with Nigeria and South Africa where 
at least 70 transplants are performed annually, other nations are challenged with inadequate facilities (Saraladevi, 2013). 
The continuous ‘brain drain’ of healthcare professionals from Africa for greener pasture has also impacted on this menace 
and has left the continent with inequitable number of qualified nephrologists to patients’ population (Eastwood et al., 2005). There 
are large rural areas of Africa that have no health professionals to serve their populations. Specifically, the proportion of 
nephrologists per million population for Kenya, Nigeria, Sudan and, South Africa stood at  0.5, 0.6, 0.7, and 1.1, respectively as 
compared to the United States with reported 16.7 nephrologists pmp (Kletke, 1997; Matri et al., 2008). Orthodox care is funded 
primarily by private facilities in most African countries, and access to medication is limited by availability of funds, except for 
Nigeria and South Africa, where public institutions and hospitals are funded by the government to provide these medications to 
indigent patients (Saraladevi, 2013).  
Globally, as at 2010 over 2 million individuals has been treated by RRT at a cost of $1 trillion. More than 100 countries 
worldwide do not have any provision for RRT and consequently, more than a million individuals can be assumed to die every year 
from ESRD. Availability of kidneys for transplantation is another important challenge consistent with RRT. Although, expenditure 
on RRT is costing about $1 trillion but the substantial percentage of patients in need of it, still remains untreated and consequently 
has out-numbered those receiving the treatment. In the early 90s, it was estimated at about 3.78 million and is expected to be doubled 
by 2020 (WHO, 2005). In Nigeria, the burden of the disease is also alarming with an estimated 15,000 new patients diagnosed 
annually. With this statistics, less than 1,000 are on dialysis out of 50,000 patients who should ideally be receiving the treatment and 
this was largely attributed to the capital intensiveness of RRT. For instance in Nigeria, it cost about $160 (=N=30,000) for a session 
of kidney dialysis and three sessions are required per week (i.e. =N=90,000 weekly). For a kidney transplant, the cost requirement is 
put at an average of $22,500 (R265, 000) and $27,500 (=N=5.5 million) in South Africa and Nigeria, respectively (IDF, 2014; NKFS, 
2015).  The alarming increase in the prevalence of CKD that progresses to ESRD requiring RRT demands huge fund allocation and 
individuals with kidney diseases are at an increasing risk of other systemic diseases which frequently proves to be fatal (Guildford, 
1991). More worrisome is the unimaginable number of mortality recorded daily from kidney failure as terminal end if dialysis or 
transplant is not performed within two weeks of diagnosis (WHO, 2005). As at 2004, over 1.7 million patients worldwide were 
receiving treatment for ESRD, of which 77% were on dialysis and 23% had functioning renal transplant, and this number is 
increasing at the rate of 7% every year (WHO, 2005). With this estimated projection, there is an urgent need for increased awareness 
among the populace, aimed at preventive measures. Societal practices that seem superficially harmless but nephrotoxic should also 
be discouraged to stem incidences of the disease and alleviate the associated burdens. Furthermore, since most patients on chronic 
dialysis cannot be sustained beyond the first 2-3 months due to financial constraints, it can thus be said that it is almost next to 
impossible to provide replacement therapy to all patients requiring it (Saraladevi, 2013). Therefore, the next option for the physicians 
is to consider suitable alternatives that will either protect kidney functions or slow the progression of the disease and delay the need 
of RRT. This will ultimately scale down the prevalence and consequently the financial burden of the disease to a significant level. 
This latter option could be viewed as paving a way for an envisaged concept that is notably termed as nephroprotection (Ahmad et 
al., 2014). 
 
Nephrotoxins and Nephroprotective Active Metabolites 
 
The pathological mechanisms of renal disease that compromises its functional capability and the structural integrity has 
been established to arise mainly through either altered intraglomerular hemodynamics, tubular cell toxicity, inflammation, crystal 
nephropathy, rhabdomyolysis, or thrombotic microangiopathy (Schnellmann and Kelly, 1999; Schectz et al., 2005; Cynthia, 2008). 
Table 1 shows some of the known nephrotoxic agents and the pathological mechanism involved in their renal pathogenesis.   
 
Table 1: Common nephrotoxicants and the mechanism (s) of action 
Class Agent Mechanism of 
renal injury 
Reference(s) 
Analgesics (NSAIDs)  Acetaminophen, Aspirin a, b, d and e (Perneger et al., 1994; Fored et al., 2001; Rossert, 
2001) 
Antibiotics: 
*Aminoglycosides 
Amphotericin B 
**β-lactam 
*Gentamicin 
**Cephalosporins, penicillins 
*f 
f 
**a and e 
(Prendergast and George, 1993; Rossert, 2001; 
Markowitz et al., 2003; Graham et al., 2004) 
Antihistamines Doxylamine, Diphenhydramine F (Coco and Klasner, 2004) 
Antiretrovirals Adefovir, cidofovir 
Indinavir 
g 
a, c 
(Rossert, 2001) 
Cardiovasculars Statins, Clopidogrel 
ACE and ARBs 
f , h, d (Pisoni et al., 2001; Palmaer, 2002; Graham et al., 
2004; Manor et al., 2004; Perazella, 2005) 
Chemotherapeutics Cisplatin, Mitomycin-C b and g, g and h (Appel, 2002) 
CNS stimulants Caffeine, cocaine etc F (Prendergast and George, 1993; Markowitz et al., 
2003) 
Diuretics Thiazides 
Triamterene 
a 
c 
(Rossert, 2001; Markowitz and Perazella, 2005) 
Heavy metals Cd, Pb, Hg, U a, d, e and f (Perazella, 1999; Tarloff, 2001) 
Immunosuppresives Sirolimus, calcineurin inhibitors a and g (Olyaei et al., 1999; Mark, 2009) 
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NSAIDs= Non-steroidal anti-inflammatory drugs, CNS= Central nervous system, a= acute interstitial nephritis, b= chronic interstitial 
nephritis, c= crystal nephropathy, d= disturbed intraglomerular hemodynamics, e= glomerulonephritis, f= rhabdomyolysis, g= tubular 
cell toxicity, and h= thrombotic microangiopathy. 
A good understanding of the pathogenic mechanism of action of these insultive agents is imperative to spotting and either 
managing or preventing renal toxicity and the associated disorders. 
Following the experimental demonstration that angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor 
blockers (ARBs), and erythropoietin slow the progression of loss of kidney function in models of kidney diseases, a treatment 
strategy to preserve renal function instead of providing supportive and passive therapy to the patients was conceived (Remuzzi et al., 
1993). The concept of nephroprotection thus emerged and strongly stimulated the clinicians to apply such concept in early detection 
and subsequent prevention of progression of the disease, mainly through lifestyle adjustment and the use of new pharmacological 
agents (Raja et al., 2014).  
Normalization of kidney function following exposure to toxicological agent involves complex processes which enhance 
kidney’s hemodynamics. A drug or agent that can assuage some or all the mechanisms highlighted in Table 1 may be an excellent 
nephroprotective agent and expectantly aid both restoration of kidney function and improvement in the structural impairment of the 
kidney, thus, slowing its progression into degenerating episodes (Remuzzi et al., 1993). Despite the fact that the mechanisms of 
action of some known orthodox drugs are yet to be substantiated, they still merit the criteria of nephroprotection owing to their 
overall efficacy on the improvement of renal function (Ahmad et al., 2014). However, the challenge even with those with well 
elucidated mechanisms (like ACE and ARBs) is the associated toxicities and side effects which have undermined their application to 
a great extent. A drug categorized to be effective as a nephroprotective agent without having liability to produce serious side effects 
will be the obvious palliative choice for the patients suffering from renal dysfunction.  Accordingly, traditional systems of medicine 
had offered effective drugs against kidney pathological conditions and thus can be used to protect renal function and prevent/slow the 
progression of renal diseases to CKD or ESRD (Naveed et al., 2014). Medicinal plants are a source for a wide variety of natural 
antioxidants and are used to treat diseases throughout the world. Their applications are mainly due to being antimicrobial, anticancer, 
anti-diabetic, anti-lipidemic, immunomodulatory, hepatoprotective and even renoprotective in action. A number of drugs from herbal 
sources in Nigeria and South Africa have been shown to be nephroprotective and there is a keen global focus on the development of 
such. Attentions are mostly on protection or prevention as well as accelerating the regeneration of tubular cells against injury to the 
kidney (Hamid and Mahmoud, 2013). Active principles of plant formulations have proven health benefits and have been elucidated 
to confer nephroprotection on the nephron of both humans and experimental animal models (Jaya, 2013). While steroid glycosides, 
terpenoids and flavonoids have been shown to preserve renal cellular macromolecules against oxidative onslaught of reactive 
metabolites and oxidative stress (Baek et al., 2006; Shelke et al., 2009; Eduardo et al., 2011), the tendency of polyphenols to protect 
the nephron against glomerulonephritis and altered intraglomerular hemodynamics in cisplatin-mediated nephrotoxic rats has been 
demonstrated (Subal et al., 2010). Table 2 presents some of these principles and their probable/specific mechanism of action.  
 
Table 2: Bioactive principles implicated in nephroprotective functions 
Active principle Mechanism of action Reference (s) 
Alkaloids Stems deleterious effect of N-acetyl-p-benzoquinoneimine on tubular 
macromolecules and improves antioxidant defense system in 
acetaminophen-treated rats 
(Palani et al., 2009; Zhao, 2013) 
Amino acids Improves altered glomerulonephritis in cisplatin-induced nephrotoxicity (Yogesh et al., 2011) 
Catechols Rescues rhabdomyolysis and acute interstitial nephritis in doxorubicin-
mediated acute nephrotoxicity 
(Ajith et al., 2008) 
Carotenoids Boosts antioxidant status and attenuates cisplatin-induced renal oxidative 
stress 
(Ranjan et al., 2009; Naghizadeh et 
al., 2010) 
Diterpenoids Repairs and assuages architectural onslaught of reactive metabolites on 
kidney functions  
(Rao, 2006) 
Flavonol glycosides Improves acute nephritis injury (Shirwaikar et al., 2004) 
Flavonoids Preserves kidney’s cellular macromolecules against oxidative insults. (Shelke et al., 2009; Kannappan et 
al., 2010) 
Glycosides Restores renal function capacity and speeds up recovery from 
glomerulonephritis, tubular cell toxicity and altered intraglomerular 
hemodynamics 
(Yadav and Khandelwal, 2009) 
Polyphenols Preserves the renal tubule against glomerulonephritis and altered 
intraglomerular hemodynamics in cisplatin-mediated nephrotoxic rats 
(Subal et al., 2010) 
Saponins Ameliorates renal carcinogenesis and improves kidney function in N-
nitrosodiethylamine-treated animals 
(Pracheta et al., 2011) 
Steroid glycosides Reduces tubular cell toxicity and crystal nephropathy in cisplatin-induced 
nephrotoxicity 
(Baek et al., 2006) 
Sterols Enhances speedy restoration of renal cellular functions via antioxidative 
action 
(Paterson, 2008; Subal et al., 2010) 
Tannins Prevents and palliates gentamicin-induced nephrotoxic insults on kidney (Kakasaheb and Rajkumar, 2011) 
Terpenoids Halts ravaging effect of generated oxidants, induced antioxidant enzymes 
and modulates mitochondrial pathway in chromium-mediated 
nephrotoxicity 
(Eduardo et al., 2011) 
Vitamins B and C Repairs tubular cell toxicity, ameliorates fluoride nephrotoxicity, aids 
renal excretion of other toxins and improves antioxidant defense system 
(Jiménez-Escrig et al., 2001) 
 
With the elucidation and isolation of these active metabolites from medicinal plants, attention is now given to the 
traditional system of medicine in providing alternative therapies to augment the increasingly expensive orthodox medical services 
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(Fasola and Egunyomi, 2005). This was well buttressed by the submission of WHO that about 80% of the population in developing 
nations seek exclusive treatment in folkloric medicine (WHO, 2000). Keeping this in view, researchers across the globe are now 
focusing on developing herbal renoprotective drugs of plant origin with antioxidant properties for the prevention and cure of kidney 
disorders (Raja et al., 2014). The exploitation of the antioxidative potentials of these plants is inseparable from the fact that oxidative 
stress is mostly implicated in episodes of renal tubular necrosis (Hamid and Mahmoud, 2013). Hence, it can be postulated that 
medicinal plants with excellent antioxidant activities due to the presence of bioactive principles may extenuate the risk of many 
chronic and degenerative diseases including nephropathy.  
 
Nephroprotective Plants from Nigeria and South Africa 
 
Globally, folkloric medicine has been and is still finding relevance in providing preventive and palliative measures against 
nephrotoxicity. Phytotherapists with keen interest in renal disorders and those informed of the unawareness and ignorance of majority 
of the victims are striving not only to educate the world on this ‘silent killer’ but also proffer extenuating panacea to its daunting 
effects. Notably, reviews on nephroprotective medicinal plants revealed appreciable success mainly from India and some other Asian 
countries and have implicated more than 300 plants with remarkable effects against several renal disorders. While Ajith et al. (2008) 
and Palani et al. (2009) have demonstrated respective therapeutic efficacy of Zingiber officinale and Pimpinella tirupatiensis on drug-
induced nephrotoxicity and oxidative stress, others have reported pharmacological significance of medicinal plants in annihilating 
oxidative insults on renal tubular cells and preserving overall kidney functions (Gaikwad et al., 2012; Mohana et al., 2012; Talele et 
al., 2012; Jaya, 2013; Raja et al., 2014).  
In Nigeria and South Africa, traditional systems of medicine are also not wanting in offering formulations/drugs for 
different forms of kidney diseases (Musabayane et al., 2007; Al-Qattan et al., 2008; Usman et al., 2009). Some of the identified 
renoprotective herbs in these countries are being embraced by physicians, and have been demonstrated to exhibit remarkable diuretic 
and antioxidative effect against known toxicants (Simpson, 1998; Kadiri et al., 2015). Plants such as curcumin, pawpaw, and bitter 
leaf are commonly and routinely cultivated in these countries and have been reported to have excellent nephroprotective capability on 
the kidneys. Assertions from some of these studies are highlighted as follows: 
 
 
Carica Papaya Linn (Caricaceae) 
 
Carica papaya is a dicotyledonous, polygamous, large, tree-like plant, with a single stem of average height 5-10 m. The 
leaves are large, 50-70 cm in diameter, deep palmately lobed, spirally arranged and confined to the top of the trunk. The flowers 
appear on the axils of the leaves, maturing into large fruit. A typical fruit of C. papaya is ripe when it feels soft and its skin has 
attained amber to orange appearance. Globally, the fruit is consumed either in its fresh form or the form of juices, jams, and 
crystallized dry fruit (Nakasone and Paull, 1998).  The nephroprotective effect of its aqueous seed extract on CCl4-perturbed renal 
damage has been reported (Olagunju et al., 2009). The authors attributed the effect elicited by the plant to its phytoconstituents and 
opined that it could have been via antioxidative and/or free radical scavenging mechanism(s). 
 
 
Zea Mays L. (Poaceae), Stigma Maydis 
 
Zea mays, Stigma maydis (Corn silk) is one of the several plant parts commonly used in the management of kidney stones, 
bedwetting and urinary infections. GCMS analysis of its aqueous extract revealed the presence of maizenic acid, β-carotene, ascorbic 
acid, gluten, o-diethyl phthalate, 2-methyl-napthalene, thymol, 3’-o-methyl-maysin, cyanidin, cinnamic acid, hordenine, luteolinidin, 
pelargonidin and betaine as major adaptogenic phytonutrients (Sabiu et al., 2016a). Although, corn is a common staple food in 
Nigeria and South Africa, the pharmacological significance of its silk is still hugely underutilized. However, its membrane 
stabilization and detoxification potential of acetaminophen-mediated oxidative onslaughts in the kidneys of Wistar rats has just been 
recently reported (Sabiu et al., 2016b). 
 
 
Agathosma Betulina (Bergius) Pillans 
 
Agathosma betulina is a flowering plant in the family Rutaceae. It is native to the lower elevation mountains of 
western South Africa, where it occurs near streams in fynbos habitats. It is an evergreen shrub growing to 2 m tall. While 
its flowers are white or pale pink with five petals, the fruit is five-parted capsule which split open to release its seeds. The leaves are 
opposite, rounded, about 20 mm long and broad, and are strongly aromatic. The essential oil from its leaves is golden in colour, with 
a strong-sweetish, peppermint-like odour and rich in isomenthone and diosphenol as major adaptogenic constituents. Leaf extracts of 
A. betulina taste like blackcurrant and is normally used as flavouring agent for teas, and has great reputation for treating kidney and 
urinary tract diseases (Moolla and Viljoen, 2008). 
 
Ficus Thonningii (Blume) (Moraceae) 
 
F. thonningii is a multistemmed, evergreen tree with a dense, rounded to spreading crown. It is native to Africa with 
distribution across the upland forests of tropical and subtropical regions, at altitudes of between 1,000-2,500 m (ATD, 2011). While 
the leaves are rounded or tapering, 4.5-12 cm long, hairless or finely hairy with a prominent midrib, the fruits are round, 10-20 mm in 
diameter, usually hairy and turn yellowish and rarely pink when ripe (Schmidt et al., 2002). Study of its stem-bark ethanolic extract 
on blood glucose, cardiovascular and kidney functions of rats, and on kidney cell lines of the proximal (LLC-PK1) and distal tubules 
(MDBK) revealed remarkable renoprotective activities and presented the plant as a source of probable lead compound in the 
management of kidney diseases (Musabayane et al., 2007). 
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Canarium Schweinfurthii Engl. (Burseraceae) 
 
C. schweinfurthii is a tall forest tree growing wild in Africa with characteristic straight and cylindrical bole exceeding 50 m 
(Orwa et al., 2009). The Leaves are pinnate, clustered at the end of the branches, and may be 15-65 cm long, with 8-12 pairs of 
leaflets. It produces fruit that is similar in appearance to olives, green in color, and red-purple when fully matured. Okwuosa et al. 
(2009) have demonstrated the potency of its stem bark extracts against acetaminophen-induced renal injuries in rats. Improved renal 
function indices and preserved histoarchitectural features were their major assertions. 
 
Sclerocarya birrea (A. Rich) Hochst. (Anacardiaceae) 
 
S. birrea is a highly valued cultural and ethnomedicinal plant in Africa. It is commonly found in semi-arid, deciduous and 
savannah regions of sub-Saharan Africa. In South Africa, S. birrea occurs in the lowlands of KwaZulu-Natal and bears edible fruit 
that has formed an integral component of the southern African diet. Literatures have indicated the presence of polyphenols, tannins, 
coumarins, flavonoids, triterpenoids and phytosterols as medicinally-important chemical constituents in its various extracts and 
standardized fractions. Treatments with stem-bark ethanolic extract of S. birrea resulted in decreased plasma urea and creatinine 
concentrations of streptozotocin-diabetic rats with concomitant increase in glomerular filtration rate (Gondwe et al., 2008). 
 
Pseudocedrela kotschyi (Schweinf.) Harms (Meliaceae) 
 
P. kotschyi is a Savanna woodland plant, chiefly of the Guinea zone on moister heavy soils of valleys. It is commonly 20-
30 m high with wide crown. While the crown is rounded with ascending branches, the bark is thick, silvery-grey and fairly regularly 
fissured into small square pieces. Antioxidative and nephroprotective activities of ethanolic roots extract of P. kotschyi against 
oxidative stress and nephrotoxicity in rats have just been recently documented (Ojewale et al., 2014). 
 
Vernonia Amygdalina, Citrullus Colocynthis, Psidium Guajava And Ficus Mucuso 
 
Vernonia amygdalina (Asteraceae), commonly known as bitter leaf is a shrub that grows up to 3 m high in the African 
tropics. It has petiolate leaves of about 6 mm diameter and elliptic shape. The leaves are green with a characteristic odour and bitter 
taste. Saponins, alkaloids, terpenes, steroids, coumarins, flavonoids, phenolic acids, lignans, xanthones, anthraquinone, edotides and 
sesquiterpenes are the pharmacologically-active constituents of V. amygdalina. 
C. colocynthis L. (Cucurbitaceae) is a tropical plant, native to Asia and Africa. Its fruit contains bitter glycoside which has 
found therapeutic significance against an array of diseases. Biologically-active phytonutrients like alkaloids and flavonoids have also 
been identified and isolated from its various extracts. 
P. guajava (Myrtaceae) is a semi deciduous tropical tree commonly called guava. Its antioxidative potentials which are 
closely associated with its numerous tannins, polyphenolic compounds, flavonoids, pentacyclic triterpenoids, guiajaverin, quercetin, 
free sugars, vitamins B1, B2, B6 and C have been documented.  
F. mucuso (Moraceae) is a tree that usually grows to a height of 30 m on mountains and stands isolated in farmlands. While 
it flowers in June, the fruits become matured in August. Phytochemical screening of its extracts revealed triterpenes, flavonoids, 
chromones and alkaloids as major bioactive constituents. 
An investigation into the probable nephroprotective attributes of V. amygdalina, C. colocynthis, P. guajava and F. mucuso 
in streptozotocin-induced diabetic animals revealed auspicious submissions and lent support to the nephroprotection concept of 
medicinal plants. However, P. guajava elicited the best and most prominent effect in preventing glomeruli disruption and also 
preserved nephro-histoarchitectural morphology of the animals (Komolafe et al., 2013). 
Though substantive focus is yet to be given to nephrophytotherapy in South Africa, efforts are ongoing in our laboratory in 
this regard. A comprehensive list of some selected plants being embraced as nephroprotective agents in Nigeria and those currently 
exploited in South Africa is presented in Table 3. 
 
Table 3: Commonly used nephroprotective plants in Nigeria and South Africa 
Plant name Part used Implicated active principle(s) Country Reference (s) 
Adansoni digitata Leaves, fruit 
pulp, bark 
Alkaloids, tannins, saponins, sterols, 
flavonoids, vitamin C 
Nigeria (Olowokudejo et al., 2008; 
Adebisi et al., 2012; Kadiri et 
al., 2015) 
Aerva lanata Whole plant Phenols, tannins, saponins, flavonoids, 
phytosterols 
Nigeria (Olowokudejo et al., 2008; 
Guarav et al., 2013) 
Agathosma betulina 
Berg. 
Leaves Flavonoids South 
Africa 
(Posthumus et al., 1996; 
Simpson, 1998) 
Allium sativum L. Cloves Phenols, flavonoids Both (Al-Qattan et al., 2008) 
Annanas comosus Whole plant Alkaloids, flavonoids, phenols, tannins, 
phytosterols, glycosides, amino acids 
Nigeria (Kataki, 2010; Kadiri et al., 
2015) 
Arachis hypogaea Nuts, leaves Glycosides, phenols, saponins Nigeria (Borokini et al., 2013; 
Rajinikanth et al., 2013; Kadiri 
et al., 2015) 
Azadirachta indica Leaves Alkaloids, flavonoids, phenols, tannins, 
saponins 
Nigeria (Harry-Asobara and Samson, 
2014; Kadiri et al., 2015)  
Bixa orellana L. Seeds, leaves Alkaloids, flavonoids, anthraquinones, 
tannins, steroids, saponins 
Nigeria (Tamil et al., 2011; Dike et al., 
2012) 
Canarium 
Schweinfurthii 
Stem-bark, 
fruits, leaves 
Tannins, steroids, cardiac glycosides Nigeria (Okwuosa et al., 2009; Ayoade 
et al., 2015) 
Sabiu et al., Afr J Tradit Complement Altern Med. (2016) 13(5):38-47 
doi:10.21010/ajtcam.v13i5.6  
43 
 
Canna indica L. Leaves, root Alkaloids, flavonoids, terpenoids, cardiac 
glycosides, steroids, tannins, saponins, 
phlobatannins 
Nigeria (Dike et al., 2012; Ali, 2015) 
Carica papaya L. Leaves, seeds Alkaloids, phenols, flavonoids, tannins, 
terpenoids, saponins 
Nigeria (Olagunju et al., 2009; Subal et 
al., 2010; Dike et al., 2012) 
Citrullus colocynthis Seed shaft Alkaloids, flavonoids Nigeria (Dallak and Bin-Jaliah, 2010; 
Komolafe et al., 2013) 
Croton zambesicus 
Muell Arg. 
Root Alkaloids, saponins, terpenes, tannins, 
phlobatannins, anthraquinones, cardiac 
glycosides 
Nigeria (Jude et al., 2011) 
Ekebergia capensis Leaves Saponins, alkaloids, flavonoids, tannins South 
Africa 
(Fitzpatrick et al., 1995) 
Ficus exasperata Vahl Leaves Saponins, steroids, glycosides, tannins Nigeria (Shagal et al., 2011; Dike et al., 
2012) 
Ficus mucuso Leaves Flavonoids, monoterpenoids Nigeria (Gojayev et al., 2011; Komolafe 
et al., 2013) 
Ficus thonningii  Leaves Alkaloids, anthraquinones, flavonoids, 
saponins, tannins 
Both (Musabayane et al., 2007; 
Usman et al., 2009) 
Foeniculum vulgare L. Leaves Phytoestrogens South 
Africa 
(Musabayane, 2012) 
Gongronema latifolium Leaves Flavonoids, saponins, polyphenols Nigeria (Ugochukwu et al., 2003; 
Ezeonwu and Dahiru, 2013) 
Harpagophytum 
procumbens 
Tubers Phenols, flavonoids South 
Africa 
(Joffe, 2005; Motlhanka, 2012) 
Harungana 
madagascariensis L. 
Root Glycosides, flavonoids, alkaloids, 
saponins and tannins 
Nigeria (Okoli et al., 2002; Adeneye et 
al., 2008) 
Helichrysum ceres S. Leaves Polyphenols, tannins, triterpenes, saponins South 
Africa 
(Musabayane et al., 2003) 
Ipomoea batatas Tubers Triterpenes, steroids, alkaloids, 
anthraquinones, flavonoids, saponins, 
tannins, phenols 
Nigeria (Márcia et al., 2011; Borokini et 
al., 2013) 
Launaea taraxacifolia Leaves Cardiac glycosides, terpenoids, tannins, 
saponins, flavonoids, steroids 
Nigeria (Adinortey et al., 2012; Borokini 
et al., 2013) 
Mallotus oppositifolius 
Mull. Arg. 
Leaves Flavonols Nigeria (Iwu, 2000; Dike et al., 2012) 
Mangifera indica L. Leaves, bark Saponin, steroids, tannin, flavonoid, 
cardiac glycosides, anthraquinone 
Nigeria (Aiyelagbe et al., 2009; Dike et 
al., 2012; Kadiri et al., 2015) 
Morinda lucida Leaves, bark Alkaloids, tannins, saponins Nigeria (Chukwuemeka et al., 2013; 
Kadiri et al., 2015) 
Ocimum gratissimum Leaves Polyphenols, flavonoids, fatty acids Nigeria (Ezeonwu and Dahiru, 2013; 
Venuprasad et al., 2014) 
Olea europaea L. Leaves Triterpenes, flavonoids, glycosides South 
Africa 
(Benavente-Garcia et al., 2000; 
Bennani-Kabchi et al., 2000) 
Opuntia megacantha Leaves Phenols, flavonoids South 
Africa 
(Bwititi et al., 2001) 
Parkia biglobosa Leaves Tannins, steroids, cardiac glycosides, 
alkaloids 
Nigeria (Ajaiyeoba, 2002; Kadiri et al., 
2015) 
Persea Americana Mill. Leaves Tannins, saponins, flavonoids, alkaloids, 
glycosides 
Both (Owolabi et al., 2010; Yasir et 
al., 2010) 
Pseudocedrela kotschyi Leaves, root Alkaloids, flavonoids Nigeria (Ojewale et al., 2014) 
Psidium guajava Leaves Glycosides, flavonoids, terpenoids Nigeria (Komolafe et al., 2013) 
Sclerocarya birrea Stem-bark Alkaloids, flavonoids, triterpenoids, 
vitamin C 
South 
Africa 
(Gondwe et al., 2008) 
Sida acuta Leaves, root Alkaloids, phytosterols, tannins, 
flavonoids, saponins 
Nigeria (Borokini et al., 2013) 
Sutherlandia frutescens Leaves Amino butyric acid, flavonol, glycosides, 
triterpenoid, saponins 
South 
Africa 
(Herbert, 2006; van Wyk and 
Albrecht, 2008) 
Syzigium spp. Seeds Flavonoids South 
Africa 
(Mapanga et al., 2009) 
Terminalia catapa Leaves, bark Alkaloids, saponins, tannins, steroids Nigeria (Muhammad and Mudi, 2011; 
Kadiri et al., 2015) 
Uvaria afzelii Leaves, bark Tannins, saponins, cardenolides, alkaloids Nigeria (Olowokudejo et al., 2008; 
Temitope et al., 2014) 
Vernonia amygdalina Leaves Tannins, flavonoids Nigeria (Eleyinmi et al., 2008; Komolafe 
et al., 2013) 
Zea mays Silk β-carotene, ascorbic acid, thymol, 
cinnamic acid, betaine 
Both (Sabiu et al., 2016a, b) 
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Conclusion 
 
Generally, efforts at increasing awareness about kidney disease and its complications in communities and among health 
professionals should be intensified. This is imperative as many are unaware of the severity of the disorder, which probably serves as 
a barrier to appropriate preventive measures. Although, thorough clinical trials and expert opinions may be necessary on medicinal 
plants to gain medical significance as preferred class of drugs, their overall auspicious and remarkable nephroprotective attributes 
have presented them as excellent candidatures to develop new lead drugs in the treatment and management of renal disorders in 
Nigeria and South Africa. 
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